![]() |
市場調查報告書
商品編碼
1801237
2025 年至 2033 年人工椎間盤市場規模、佔有率、趨勢及預測(按椎間盤類型、材料類型、最終用戶和地區)Artificial Disc Market Size, Share, Trends and Forecast by Disc Type, Material Type, End User, and Region, 2025-2033 |
2024年,全球人工椎間盤市場規模達36.3億美元。展望未來, IMARC Group預測,到2033年,該市場規模將達到138.4億美元,2025-2033年期間的複合年成長率為15.24%。北美市場佔據主導地位,2024年市佔率高達56.2%。人口老化、先進的醫療保健、優惠的報銷政策以及強大的醫療器材市場是人工椎間盤市場佔有率成長的部分因素。
市場成長主要受退化性椎間盤疾病及相關脊椎疾病日益成長的盛行率所驅動,尤其是在老年人口中。患者擴大尋求脊椎融合的替代方案,青睞保留運動功能的手術,例如全椎間盤置換術。植入物技術的進步,例如改進的生物材料、解剖設計和多層次相容性,顯著提高了臨床療效和患者滿意度。強力的長期資料顯示,人工椎間盤的耐用性、較低的翻修率以及對脊椎活動性的保留,進一步支持了其應用。由於手術技術的進步和臨床證據的不斷增加,外科醫生在推薦這些器械時也更有信心。多個地區優惠的報銷框架和不斷增加的醫療保健投資也促進了人工椎間盤市場的成長。此外,患者對新型、微創脊椎治療的認知不斷提高,這有助於刺激對人工椎間盤作為慢性背痛和脊椎不穩定的長期解決方案的需求。
美國針對治療退化性椎間盤疾病的髓核置換裝置的臨床研究活動正在增加。新的試驗重點關注可保留椎間盤功能的微創方案,這反映出人們對拓展人工椎間盤技術(超越傳統全椎間盤置換術)以及提供更有針對性的治療方法的持續興趣。例如,2025年3月,Spinal Stabilization Technologies, LLC宣布其PerQdisc髓核置換裝置(NRD)的臨床試驗已招募首位美國受試者。此舉標誌著SST在美國進行的試驗正式啟動,該試驗旨在評估其PerQdisc人工椎間盤裝置對退化性椎間盤退化(DDD)患者的療效。
脊椎運動保護解決方案日益受到青睞
全球人口老化導致脊椎疾病(尤其是退化性椎間盤疾病)發生率持續上升。隨著越來越多的人尋求維持活動能力和生活品質的解決方案,人工椎間盤置換手術正逐漸取代傳統的融合手術。人工椎間盤市場趨勢的一個關鍵特徵是,越來越多的人轉向微創手術技術,這源於人們對更快康復、更短住院時間和更低併發症發生率的需求。隨著手術工具的改進和醫療服務提供者專業技能的不斷提升,這些手術也變得越來越普及。老化患者群體的增加以及微創手術方法的進步,使得人工椎間盤在頸椎和腰椎領域的應用和吸引力穩步提升。根據世界衛生組織的數據,到 2050 年,60 歲及以上的老年人口預計將佔全球總人口的 22%。根據IMARC Group的報告,全球微創手術市場規模在 2024 年也將達到 561 億美元,預計在 2025-2033 年期間的複合年成長率為 5.72%。
臨床驗證增強了人們對腰椎間盤植入物的信心
近期的長期臨床研究結果增強了人們對人工腰椎間盤置換術的信心,尤其是涉及先前手術的複雜病例。一項重要的長期追蹤研究證明了廣泛使用的腰椎間盤系統具有良好的安全性和耐用性。患者在單節段和雙節段手術中均表現出持續的正面效果,很少有患者需要進行後續修復。這些結果有助於驗證人工椎間盤作為治療退化性椎間盤疾病的可靠選擇的作用,並支持其在脊椎護理中的日益普及。人工椎間盤市場前景仍然樂觀,因為外科醫生和醫療保健系統可能會更依賴此類成熟的設備,長期資料將繼續支持其在維持運動和減少二次干預需求方面的有效性。例如,《骨與關節外科雜誌》於2024年12月在線發表的一項具有里程碑意義的研究證實了Centinel Spine公司的prodisc L人工腰椎間盤的長期成功。研究納入了1187名患者,追蹤時間為7至21年。研究結果顯示,單節段和雙節段病例(包括既往手術史)的翻修率較低(0.67%),且療效良好。這些發現進一步證明了prodisc L在治療退化性椎間盤疾病方面的耐用性和安全性。
跨境脊椎手術的作用不斷擴大
隨著患者尋求國外更高品質、更低成本的醫療服務,醫療旅遊對人工椎間盤產業的影響日益增強。隨著越來越多的人選擇出國接受先進的脊椎手術,人工椎間盤市場預測反映了不斷成長的國際需求,尤其是在擁有高技能外科醫生、現代化設施和經濟實惠治療方案的地區。跨境治療的吸引力日益增強,這得益於手術標準的提高、國際認可的醫院以及人工椎間盤置換等先進手術的普及。患有慢性背痛的患者擴大尋求海外治療,在那裡,經驗豐富的外科醫生可以以極具競爭力的價格進行保留運動的脊椎手術。這種趨勢不僅限於擇期手術,也正在影響複雜脊椎治療的實施方式和地點。隨著越來越多的國家將自身定位為專科護理中心,人工椎間盤技術正在傳統市場以外的新患者群體中獲得關注和應用。例如,根據IMARC Group的數據,全球醫療旅遊市場規模在2024年達到1,445億美元,預計2025年至2033年的複合年成長率將達到19.08%。
The global artificial disc market size was valued at USD 3.63 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 13.84 Billion by 2033, exhibiting a CAGR of 15.24% during 2025-2033. North America dominated the market, holding a significant market share of 56.2% in 2024. Aging population, advanced healthcare, favorable reimbursement, and strong medical device presence are some of the factors contributing to the artificial disc market share.
The market is primarily driven by the growing prevalence of degenerative disc disease and related spinal disorders, especially among aging populations. Patients increasingly seek alternatives to spinal fusion, favoring motion-preserving procedures like total disc replacement. Advances in implant technology, such as improved biomaterials, anatomical designs, and multi-level compatibility, have significantly enhanced clinical outcomes and patient satisfaction. Strong long-term data demonstrating durability, low revision rates, and preservation of spinal mobility further support adoption. Surgeons are more confident in recommending these devices due to improved surgical techniques and growing clinical evidence. Favorable reimbursement frameworks in several regions and increasing healthcare investments also contribute to the artificial disc market growth. Additionally, patient awareness about newer, less invasive spinal treatments continues to rise, helping fuel demand for artificial discs as a long-term solution to chronic back pain and spinal instability.
Clinical research activity in the US is increasing for nucleus replacement devices aimed at treating degenerative disc conditions. New trials are focusing on minimally invasive options that preserve disc function, reflecting continued interest in expanding artificial disc technologies beyond traditional total disc replacements and offering more targeted treatment approaches. For instance, in March 2025, Spinal Stabilization Technologies, LLC announced the enrollment of the first U.S. individual in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD). This development marks the official commencement of SST's U.S.-based trial to assess its PerQdisc artificial disc device for patients with degenerative disc degeneration (DDD).
Growing Preference for Motion-Preserving Spine Solutions
An aging global population is contributing to a steady rise in spinal conditions, particularly degenerative disc disorders. As more individuals seek solutions that maintain mobility and quality of life, artificial disc replacement is gaining traction over traditional fusion surgeries. A key feature of artificial disc market trends is the growing shift toward less invasive surgical techniques, driven by demand for faster recovery, reduced hospital stays, and lower complication rates. These procedures are becoming more accessible due to improvements in surgical tools and growing expertise among healthcare providers. The combination of an older patient base and advancements in minimally invasive methods is steadily increasing the appeal and use of artificial discs in both cervical and lumbar applications. According to the World Health Organization, the number of geriatric individuals aged 60 years and over is expected to account for 22% of the total global population by 2050. The global minimally invasive surgery market also reached USD 56.1 Billion in 2024 and is forecasted to grow at a CAGR of 5.72% during 2025-2033, as per a report by the IMARC Group.
Clinical Validation Strengthening Confidence in Lumbar Disc Implants
Recent long-term clinical findings have reinforced confidence in lumbar artificial disc replacements, especially in complex cases involving prior surgeries. A major study with extended follow-up demonstrated strong safety and durability outcomes for a widely used lumbar disc system. Patients showed consistently positive results in both single- and two-level procedures, with very few requiring revisions over time. These results help validate the role of artificial discs as a dependable option for treating degenerative disc disease, supporting their growing use in spine care. The artificial disc market outlook remains positive as surgeons and healthcare systems are likely to rely more on such proven devices, with long-term data continuing to support their effectiveness in preserving motion and reducing the need for secondary interventions. For example, a landmark study published online in December 2024 by the Journal of Bone & Joint Surgery confirmed the long-term success of Centinel Spine's prodisc L lumbar artificial disc. Involving 1,187 patients with 7-21 years of follow-up, the study reported a low revision rate (0.67%) and strong outcomes across 1- and 2-level cases, including prior surgeries. These findings reinforce the durability and safety of prodisc L in treating degenerative disc disease.
Expanding Role of Cross-Border Spine Procedures
Medical travel is becoming a stronger influence on the artificial disc industry, as patients seek high-quality care at lower costs outside their home countries. With more individuals traveling for advanced spine procedures, the artificial disc market forecast reflects growing international demand, especially in regions offering skilled surgeons, modern facilities, and cost-effective treatment options. The growing appeal of cross-border treatment is supported by improved surgical standards, internationally accredited hospitals, and access to advanced procedures like artificial disc replacement. Individuals dealing with chronic back pain are increasingly exploring options abroad where skilled surgeons perform motion-preserving spine surgeries at competitive prices. This movement is not limited to elective procedures; it's also shaping how and where complex spine treatments are delivered. As more countries position themselves as hubs for specialized care, artificial disc technologies are gaining visibility and adoption across new patient populations beyond traditional markets. For instance, the global medical tourism market reached USD 144.5 Billion in 2024 and is projected to grow at a CAGR of 19.08% from 2025-2033, according to the IMARC Group.
Cervical artificial disc stood as the largest disc type in 2024, holding around 65.9% of the market due to rising demand for less invasive solutions to cervical spine degeneration. These discs are used to replace damaged intervertebral discs in the neck and help preserve natural motion, unlike spinal fusion, which restricts it. Increasing prevalence of cervical degenerative disc disease among the aging population and a growing preference for motion-preserving surgeries are pushing hospitals and surgeons to opt for artificial cervical discs. Technological advancements have improved implant materials and surgical techniques, reducing complication rates and speeding up recovery. Reimbursement support in developed countries and favorable long-term clinical outcomes are encouraging wider adoption. This segment is also gaining momentum due to expanding regulatory approvals and its proven ability to reduce adjacent segment degeneration compared to traditional methods.
Metal on polymer led the market with around 64.2% of market share in 2024, owing to its favorable clinical performance, durability, and cost-effectiveness. These implants typically use a metal endplate and a polymer core, offering smoother articulation and reducing wear compared to metal-on-metal designs. Surgeons favor this configuration because it mimics natural disc movement while minimizing the risk of metal ion release, a concern with some older implant types. Patients benefit from improved mobility and lower complication rates. Manufacturers continue refining polymer materials to enhance strength and longevity, making them more suitable for long-term implantation. The segment's popularity is rising in both cervical and lumbar applications, especially in regions where price sensitivity matters. Regulatory approvals and clinical success stories are further boosting adoption, making metal-on-polymer a preferred option in artificial disc replacement procedures.
Hospitals and clinics led the market with around 70.8% of market share in 2024 because of increased patient volume, better surgical infrastructure, and access to advanced spinal procedures. These facilities are often the first choice for patients seeking treatment for degenerative disc disorders, especially as awareness grows about alternatives to spinal fusion. Hospitals and large clinics are equipped with skilled orthopedic and neurosurgeons, imaging systems, and post-operative care units that support complex procedures like artificial disc replacement. They also benefit from direct partnerships with device manufacturers, ensuring the timely availability of approved implants. With rising healthcare spending and government investments in surgical capabilities, particularly in urban areas, more hospitals are incorporating motion-preserving spinal surgeries into their standard offerings. Insurance coverage and reimbursement support are typically more accessible through hospital networks, making them central to the rising demand for artificial disc implants.
In 2024, North America accounted for the largest market share of over 56.2%. The region has a high volume of spinal surgeries, driven by a large aging population prone to degenerative disc disorders. Access to advanced healthcare facilities and skilled surgeons also plays a major role. Regulatory support and quicker approvals from authorities like the FDA have helped bring new technologies to market faster. Insurance coverage and favorable reimbursement policies make artificial disc replacement a viable option for more patients. Additionally, the presence of key medical device manufacturers in the U.S. ensures faster product availability and continued innovation. Public awareness of spinal health and early treatment has also improved adoption. Together, these factors have established North America as the leading region in the artificial disc market, with strong growth potential going forward.
United States Artificial Disc Market Analysis
In 2024, the United States accounted for 87.7% of the market share in North America. The growth of the US artificial disc market is primarily driven by the increasing prevalence of spine-related disorders, such as degenerative disc disease and other spinal disorders, which require advanced treatment solutions. According to the National Spine Health Foundation, evidence of disc degeneration is found in approximately 90% of individuals aged 60 years and older. The rising geriatric population is a significant factor, as age-related spinal issues are more common among older adults, creating a greater demand for artificial disc replacement (ADR) procedures. Additionally, the growing preference for minimally invasive procedures over traditional spinal fusion surgeries is contributing substantially to market growth, as ADR offers benefits such as faster recovery times, less pain, and improved range of motion. The rise in healthcare expenditure and investment in the healthcare sector, along with the availability of advanced surgical techniques, is also supporting the market. According to the Centers for Medicare and Medicaid Services (CMS), healthcare expenditures in the United States increased by 7.5% in 2023, reaching USD 4.9 Trillion or USD 14,570 per person and accounting for 17.6% of the GDP of the country. Other than this, reimbursement policies for spine surgeries and ADR procedures are becoming more favorable, which boosts the accessibility of artificial disc surgeries, further driving market growth.
Asia Pacific Artificial Disc Market Analysis
The Asia Pacific artificial disc market is expanding due to a rising incidence of spinal injuries, particularly related to lifestyle changes, high mobility in urban populations, and sports-related trauma, which has led to greater demand for artificial disc replacement (ADR) procedures. For instance, the incidence of spinal cord injuries (SCI) in China reached 99,363 cases in 2021, marking an increase of 43.27% since 1990. The prevalence of SCI reached 2,766,277 cases, recording a growth of 63.27% since 1990. Additionally, the region's growing focus on healthcare modernization and the adoption of advanced medical technologies is making ADR more accessible. Increased investments in healthcare infrastructure and the establishment of specialized spinal surgery centers across emerging markets are contributing substantially to industry expansion. For instance, in August 2023, the specialized Institute of Brain & Spine was established at Radial Road's Kauvery Hospital in India. The Institute provides exceptional facilities, cutting-edge technologies, and a skilled group of specialized physicians that achieve the intended clinical results, enhancing the quality of life for each and every one of its patients.
Europe Artificial Disc Market Analysis
The growth of the Europe artificial disc market is largely fueled by the rising demand for advanced spinal treatments. A notable growth-inducing factor is the increasing incidence of degenerative disc diseases, herniated discs, and spinal disorders, particularly among the geriatric population, which is more susceptible to such conditions. For instance, over 50% of the average population suffers from a non-symptomatic herniated disc. Moreover, in European nations, the percentage of hospital discharges connected to spine disorders ranged from 0.8% to 4.3% of all hospital discharges and from 14.2% to 45.6% of all discharges related to musculoskeletal disorders in 2019, according to a study by the National Institutes of Health. Furthermore, in Europe, intervertebral disc problems alone were responsible for 4.9% to 21.1% of all hospital discharges resulting from musculoskeletal disorders. Additionally, the growing preference for patient-centric treatment options, focused on enhancing quality of life and long-term mobility, is significantly propelling the widespread adoption of ADR. Collaborative research and development (R&D) between European medical institutions and manufacturers have also led to more refined, patient-friendly products, further encouraging the adoption of ADR. The expansion of clinical evidence supporting the long-term benefits of ADR, along with the endorsement of professional medical societies, is further fostering market confidence and adoption.
Latin America Artificial Disc Market Analysis
The Latin America artificial disc market is significantly influenced by the growing incidence of spinal conditions. For instance, 19% of individuals in Brazil aged 18 years and above reported suffering from chronic spinal pain. Moreover, the demand for minimally invasive surgeries is rising as patients seek less invasive treatments with quicker recovery times, making artificial disc replacement (ADR) an attractive alternative to traditional spinal fusion surgeries. Improvements in healthcare infrastructure and access to advanced medical technologies in countries such as Brazil and Mexico are also making ADR procedures more available. Besides this, increasing awareness about the benefits of ADR, along with favorable reimbursement policies and rising disposable incomes, are substantially driving market growth, allowing more patients to afford advanced spinal care solutions.
Middle East and Africa Artificial Disc Market Analysis
The Middle East and Africa artificial disc market is experiencing robust growth, driven by the increasing demand for advanced spinal treatments due to a higher incidence of lifestyle-related spinal issues and injuries. Moreover, the region's expanding healthcare infrastructure is making ADR procedures more accessible. Growing healthcare investments and expenditures, particularly in countries such as the UAE and Saudi Arabia, are further contributing to better availability of specialized treatments. For instance, the Government of Saudi Arabia allocated SR 86,253,063 to the Ministry of Health for FY25, equating to 7% of the state budget. Besides this, increased awareness and education about ADR benefits, along with favorable healthcare policies and insurance coverage, are also driving industry expansion in the region.
The artificial disc market is experiencing notable growth, driven by technological advancements and strategic initiatives. Recent developments include the introduction of innovative products like NGMedical's MOVE-C cervical disc and Orthofix's M6-C, which have demonstrated superior clinical outcomes. Companies such as NuVasive and Centinel Spine are actively engaging in partnerships and acquisitions to enhance their product offerings and market presence. Research and development efforts are focused on new biomaterials and 3D printing techniques to create customized implants, improving patient outcomes. Government initiatives, including increased funding and supportive reimbursement policies, are facilitating the adoption of artificial disc procedures. Among these activities, product launches and strategic collaborations are currently the most prevalent practices, reflecting the industry's emphasis on innovation and market expansion.